Skip to main content
. 2018 Aug;9(4):741–749. doi: 10.21037/jgo.2018.05.13

Figure 1.

Figure 1

Flow chart of the patients. There were 385 initial patients’ records with hepatocellular carcinoma of whom 66 with advanced hepatocellular carcinoma were included in the final analyses. These 66 patients were divided into the B-HAIC group and the sorafenib group. B-HAIC, bi-monthly hepatic arterial infusion chemotherapy.